Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris

ClinicalTrials.gov ID: NCT03573518

Public ClinicalTrials.gov record NCT03573518. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 5:50 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to assess safety and efficacy of various doses of BTX 1503 liquid formulation in subjects with moderate to severe acne vulgaris of the face.

Study identification

NCT ID
NCT03573518
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Botanix Pharmaceuticals
Industry
Enrollment
368 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years to 40 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 26, 2018 (Actual)
Primary completion
Aug 16, 2019 (Actual)
Completion
Sep 5, 2019 (Actual)
Last update posted
Apr 18, 2022

2018 – 2019

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
Applied Research Center of Arkansas Little Rock Arkansas 72212 —
Encino Research Center Encino California 91436 —
Dermatology Specialist, Inc. Murrieta California 92562 —
Quest Dermatology Research Northridge California 91324 —
Clinical Science Insitute Santa Monica California 90404 —
Well Phrama Medical Research Miami Florida 33143 —
Tory Sullivan, M.D., PA North Miami Beach Florida 33162 —
Precision Clinical Research Sunrise Florida 33351 —
DS Research - Louisville Louisville Kentucky 40241 —
Delricht Research New Orleans Louisiana 70115 —
Metro Boston Clinical Brighton Maine 02135 —
Minnesota Clinical Study Center Fridley Minnesota 55432 —
Medisearch Clinical Trials Saint Joseph Missouri 64506 —
Washington University School of Medicine - Dermatology St Louis Missouri 63141 —
JDR Dermatology Research Las Vegas Nevada 89148 —
The Acne Treatment and Research Center Morristown New Jersey 07960 —
Aventiv Research Dublin Ohio 43016 —
Penn State Hershey Medical Hershey Pennsylvania 17033 —
Clinical Partners, LLC Johnston Rhode Island 02919 —
Greenville Dermatology, LLC Greenville South Carolina 29607 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464 —
Avant Research Associates, LLC Austin Texas 78704 —
DermReasearch Austin Texas 78759 —
J&S Studies, Inc. College Station Texas 77845 —
Suzanne Bruce and Associates, PA Houston Texas 77056 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03573518, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 18, 2022 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03573518 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →